Current clinical applications of coronary optical coherence tomography
- 1.1k Downloads
Optical coherence tomography (OCT) is an intra-coronary diagnostic technique that provides detailed imagings of blood vessels in the current cardiac catheterization laboratory. The higher resolution of OCT often provides superior delineation of each structure compared with intravascular ultrasound (IVUS), and it can reliably visualize the microstructure of normal and diseased arteries. The capabilities of OCT are well suited for the identification of calcified plaque and neointima formation after stent implantation. It has been reported that OCT-guided percutaneous coronary intervention (PCI) resulted in equivalent clinical and angiographic outcomes in comparison with IVUS-guided PCI. Recently, the three-dimensional reconstruction of OCT and a real-time point-to-point correspondence between coronary angiographic and OCT/OFDI images have been developed and provide useful information to PCI operators. The unique capabilities of OCT as an investigational tool for high-risk lesions will serve the cardiology community well, as it moves us toward a better understanding of atherosclerotic plaque. In addition, because of the development of new OCT technology, OCT has become a notable catheter-based imaging technology that can provide practical guidance for PCI in clinical settings.
KeywordsOptical coherence tomography Imaging Vulnerable plaque Thrombus Coronary intervention
Optical coherence tomography (OCT) is an intra-coronary diagnostic technique that provides detailed imagings of blood vessels in the current cardiac catheterization laboratory. The first OCT system was developed by a group of James G. Fujimoto in 1991 . By the early 2000s, the first images of human coronary atherosclerosis were recorded by Yabushita and colleagues . In 2008, the first commercially available time-domain OCT system (M2 OCT imaging system, LightLab Imaging, Inc., Westford, MA, USA) was introduced and included under insurance coverage in Japan. However, the time-domain OCT system needed an over-the-wire-type catheter with an occlusion balloon to obtain continuous long-sectional images due to the limitation of pullback speed. Therefore, the application of time-domain OCT was mostly limited to research purposes. More recently, new generation OCT systems, such as frequency-domain OCT and optical frequency-domain imaging (OFDI) systems, have been developed to overcome this limitation . Since then, OCT has become a noticeable catheter-based imaging technology that can provide scientific insights into vascular biology and practical guidance for percutaneous intervention (PCI) in clinical settings. In the current review article, updates on OCT image interpretation and clinical applications of coronary OCT are discussed.
OCT image interpretation
Coronary artery morphology
The higher resolution of OCT often provides superior delineation of each structure compared with intravascular ultrasound (IVUS), and it can reliably visualize the microstructure (i.e., 15–50 vs. 150–200 µm for IVUS) of normal and diseased arteries. Typically, the media of the vessel appear as a lower signal intensity band than the intima and adventitia, providing a three-layered appearance. There is good agreement in the intimal thickness between OCT and histological examination (r = 0.98, p < 0.001, mean difference = 0.01 ± 0.04 mm) . Most adults undergoing cardiac catheterization have intimal thickening and a signal-rich thick intimal band, even in angiographically normal segments. OCT signal penetration through the diseased arterial wall is generally more limited (no more than 2 mm with current OCT devices), making it difficult to investigate deeper portions of the artery or to track the entire circumference of the media–adventitia interface.
Detection of vulnerable plaque
One of the most valuable challenges for OCT is its role in the detection of vulnerable plaque. Myocardial infarction, sudden cardiac death, and unstable angina arise from coronary thrombosis, which mainly develops as a result of ruptured vulnerable plaque. Autopsy studies have identified several histological characteristics of plaques that correlate with the risk of rupture and subsequent acute coronary events. These characteristics include: (1) a large necrotic core with an overlying thin fibrous cap (<65 µm), so-called thin-cap fibroatheroma (TCFA); (2) activated macrophages near the fibrous cap; and (3) neoangiogenesis . A TCFA is characterized as a necrotic core with an overlying fibrous cap. A fibrous cap consists of vascular smooth muscle cell and extracellular matrix, which is often a signal-rich band, overlying a signal-poor region indicating the necrotic core. In the OCT image, the necrotic core is characterized as signal-poor regions with poorly defined borders, similar to that of a lipid pool. Histologically, a lipid pool is converted to a necrotic core by macrophage infiltration and apoptosis forming the early necrotic core. In previous studies by a combination of pathohistology and OCT, researchers did not attempt to differentiate a necrotic core from a lipid pool, although these structures have different clinical relevance [2, 7]. Recently, Fujii and colleagues reported that the histological findings underlying the false-positive diagnoses of OCT for TCFA included foam cell accumulation on the luminal surface, microcalcifications at the surface, hemosiderin accumulation, or organized thrombus . It seems likely that the diagnostic accuracy for OCT-derived TCFA was not higher than expected, so the ability of OCT to characterize a lipid pool containing necrotic core needs to be clarified in future histologic studies.
The unique capabilities of OCT as an investigational tool for high-risk lesions will serve the cardiology community well, as it moves us toward a better understanding and identification of vulnerable plaque, thereby improving our ability to more precisely treat our patients, both acutely and for the long term.
Assessment of neointima
The capabilities of OCT are well suited for the identification of neointima formation, where the relevant morphologic features are primarily localized within 500 μm of the luminal surface. Previous ex vivo studies have reported that OCT can characterize neointimal tissue morphologies following coronary stent implantation [19, 20, 21]. Homogeneous neointima including predominantly smooth muscle cells with collagen fibers is typically observed after bare-metal stent implantation, and it has been reported that homogeneous neointima is a predictor of late neointimal regression during 18 month follow-up . On the other hand, heterogeneous neointima contains various tissue components, such as proteoglycan-rich myxomatous matrix, calcium deposition, foam cell accumulation, and fibroatheroma. Heterogeneous neointima with high attenuation that cause invisible stent struts indicates a large amount of foam cell accumulation and large fibroatheroma/necrotic core within neointima. Such heterogeneous neointima, so-called neo-atherosclerosis, is a frequent finding in lesions with drug-eluting stent implantation and observed earlier than in bare-metal stent implantation . Although the mechanism of very late stent thrombosis is multifactorial , rupture of an atheromatous lesion within the stented segment (neointimal rupture) may be associated with the occurrence of very late stent thrombosis. OCT is useful for monitoring the morphological changes that occur in neointima formation after stent implantation. In addition, when various types of PCI, including plain old balloon angioplasty, paclitaxel-coated balloon dilatation, and drug-eluting stent implantation, for in-stent restenosis (ISR) lesions were compared, target lesion revascularization (TLR) rates of lesions with a homogeneous neointima were significantly higher in the plain old balloon angioplasty group than in the paclitaxel-coated balloon dilatation group (ISR: 54.8 vs. 19.1%, p < 0.001; TLR: 38.7 vs. 10.6%, p < 0.001) and drug-eluting stent group (ISR: 54.8 vs. 19.6%, p = 0.002; TLR: 38.7 vs. 10.7%, p = 0.005), whereas there were no differences among the three groups in lesions with a heterogeneous structure . These results suggested that treatment using a paclitaxel-coated balloon or drug-eluting stent group might be preferable for ISR lesions with homogeneous neointima compared with plain old balloon angioplasty. Morphological assessment of neointima in lesions with ISR using OCT provides useful information about suitable PCI strategies for ISR lesions.
Guidance for coronary interventions
In terms of the comparison between angiography alone vs. angiography plus OCT-guided PCI, it has been reported that OCT-guided PCI had a significantly lower 1-year risk of cardiac death (1.2 vs. 4.5%, p = 0.010), cardiac death or myocardial infarction (6.6 vs. 13.0%, p = 0.006), and the composite of cardiac death, myocardial infarction, or repeat revascularization (9.6 vs. 14.8%, p = 0.044) . This study was a case–control study and further large-scale prospective, randomized studies are needed to reveal the clinical superiority of OCT-guided PCI against angiography alone PCI. Regarding the comparison between OCT-guided and IVUS-guided PCI, Habara and colleagues first reported that OCT guidance for stent implantation was associated with smaller stent expansion than the conventional IVUS guidance in a single-center study. This result might be due to the poor visibility of the vessel border using OCT, which contributes to smaller stent expansion than with IVUS guidance. However, in a recent post hoc analysis, OCT and IVUS guidance for PCI resulted in a comparable degree of stent expansion . More recently, in a randomized, controlled trial (ILUMIEN III: Optimize PCI trial), OCT-guided PCI using a specific reference segment external elastic lamina-based stent optimization strategy was safe and resulted in a similar degree of stent expansion to that of IVUS-guided PCI . It has been reported that OFDI-guided PCI resulted in equivalent clinical and angiographic outcomes at 12 months in a multicenter, randomized, controlled trial (OPINION trial) . Further large-scale prospective studies are needed to compare the outcomes between OCT-guided PCI and IVUS-guided PCI.
Co-registration of OCT with coronary angiography
The unique capabilities of OCT as an investigational tool for high-risk lesions will serve the cardiology community well, as it moves us toward a better understanding of atherosclerotic plaque. In addition, because of the development of new OCT technology, OCT has become a notable catheter-based imaging technology that can provide practical guidance for PCI in clinical settings.
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
- 3.Takarada S, Imanishi T, Liu Y, Ikejima H, Tsujioka H, Kuroi A, Ishibashi K, Komukai K, Tanimoto T, Ino Y, Kitabata H, Kubo T, Nakamura N, Hirata K, Tanaka A, Mizukoshi M, Akasaka T. Advantage of next-generation frequency-domain optical coherence tomography compared with conventional time-domain system in the assessment of coronary lesion. Catheter Cardiovasc Interv. 2010;75:202–6.CrossRefPubMedGoogle Scholar
- 8.Fujii K, Hao H, Shibuya M, Imanaka T, Fukunaga M, Miki K, Tamaru H, Sawada H, Naito Y, Ohyanagi M, Hirota S, Masuyama T. Accuracy of OCT, grayscale IVUS, and their combination for the diagnosis of coronary TCFA: an ex vivo validation study. JACC Cardiovasc Imaging. 2015;8:451–60.CrossRefPubMedGoogle Scholar
- 12.Uemura S, Ishigami K, Soeda T, Okayama S, Sung JH, Nakagawa H, Somekawa S, Takeda Y, Kawata H, Horii M, Saito Y. Thin-cap fibroatheroma and microchannel findings in optical coherence tomography correlate with subsequent progression of coronary atheromatous plaques. Eur Heart J. 2012;33:78–85.CrossRefPubMedGoogle Scholar
- 14.Jia H, Abtahian F, Aguirre AD, Lee S, Chia S, Lowe H, Kato K, Yonetsu T, Vergallo R, Hu S, Tian J, Lee H, Park SJ, Jang YS, Raffel OC, Mizuno K, Uemura S, Itoh T, Kakuta T, Choi SY, Dauerman HL, Prasad A, Toma C, McNulty I, Zhang S, Yu B, Fuster V, Narula J, Virmani R, Jang IK. In vivo diagnosis of plaque erosion and calcified nodule in patients with acute coronary syndrome by intravascular optical coherence tomography. J Am Coll Cardiol. 2013;62:1748–58.CrossRefPubMedGoogle Scholar
- 18.Terashima M, Awano K, Honda Y, Yoshino N, Mori T, Fujita H, Ohashi Y, Seguchi O, Kobayashi K, Yamagishi M, Fitzgerald PJ, Yock PG, Maeda K. Images in cardiovascular medicine. “Arteries within the artery” after Kawasaki disease: a lotus root appearance by intravascular ultrasound. Circulation. 2002;106:887.CrossRefPubMedGoogle Scholar
- 19.Imanaka T, Fujii K, Hao H, Shibuya M, Saita T, Kawakami R, Fukunaga M, Kawai K, Tamaru H, Miki K, Horimatsu T, Sumiyoshi A, Nishimura M, Hirota S, Masuyama T, Ishihara M. Ex vivo assessment of neointimal characteristics after drug-eluting stent implantation: optical coherence tomography and histopathology validation study. Int J Cardiol. 2016;221:1043–7.CrossRefPubMedGoogle Scholar
- 21.Shibuya M, Fujii K, Hao H, Imanaka T, Saita T, Fukunaga M, Miki K, Tamaru H, Nishimura M, Horimatsu T, Naito Y, Ishibashi-Ueda H, Hirota S, Masuyama T. Tissue characterization of in-stent neointima using optical coherence tomography in the late phase after bare-metal stent implantation–an ex vivo validation study. Circ J. 2015;79:2224–30.CrossRefPubMedGoogle Scholar
- 25.Tada T, Kadota K, Hosogi S, Miyake K, Ohya M, Amano H, Izawa Y, Kanazawa T, Kubo S, Ichinohe T, Hyoudou Y, Hayakawa Y, Sabbah MM, Otsuru S, Hasegawa D, Habara S, Tanaka H, Fuku Y, Katoh H, Goto T, Mitsudo K. Association between tissue characteristics assessed with optical coherence tomography and mid-term results after percutaneous coronary intervention for in-stent restenosis lesions: a comparison between balloon angioplasty, paclitaxel-coated balloon dilatation, and drug-eluting stent implantation. Eur Heart J. 2015;16:1101–11.Google Scholar
- 29.Prati F, Di Vito L, Biondi-Zoccai G, Occhipinti M, La Manna A, Tamburino C, Burzotta F, Trani C, Porto I, Ramazzotti V, Imola F, Manzoli A, Materia L, Cremonesi A, Albertucci M. Angiography alone versus angiography plus optical coherence tomography to guide decision-making during percutaneous coronary intervention: the centro per la lotta contro l’infarto-optimisation of percutaneous coronary intervention (CLI-OPCI) study. EuroIntervention. 2012;8:823–9.CrossRefPubMedGoogle Scholar
- 30.Maehara A, Ben-Yehuda O, Ali Z, Wijns W, Bezerra HG, Shite J, Genereux P, Nichols M, Jenkins P, Witzenbichler B, Mintz GS, Stone GW. Comparison of stent expansion guided by optical coherence tomography versus intravascular ultrasound: the ILUMIEN II study (observational study of optical coherence tomography [OCT] in patients undergoing fractional flow reserve [FFR] and percutaneous coronary intervention). JACC Cardiovasc Interv. 2015;8:1704–14.CrossRefPubMedGoogle Scholar
- 31.Ali ZA, Maehara A, Genereux P, Shlofmitz RA, Fabbiocchi F, Nazif TM, Guagliumi G, Meraj PM, Alfonso F, Samady H, Akasaka T, Carlson EB, Leesar MA, Matsumura M, Ozan MO, Mintz GS, Ben-Yehuda O, Stone GW, Investigators IIOP. Optical coherence tomography compared with intravascular ultrasound and with angiography to guide coronary stent implantation (ILUMIEN III: Optimize PCI): a randomised controlled trial. Lancet. 2016;388:2618–28.CrossRefPubMedGoogle Scholar
- 32.Kubo T. Opinion: optical frequency domain imaging vs. Intravascular ultrasound in percutaneous coronary intervention. In: Presented at: EuroPCR, Paris; 2016.Google Scholar
- 33.Tearney GJ, Waxman S, Shishkov M, Vakoc BJ, Suter MJ, Freilich MI, Desjardins AE, Oh WY, Bartlett LA, Rosenberg M, Bouma BE. Three-dimensional coronary artery microscopy by intracoronary optical frequency domain imaging. JACC Cardiovasc Imaging. 2008;1:752–61.CrossRefPubMedPubMedCentralGoogle Scholar
- 34.Alegria-Barrero E, Foin N, Chan PH, Syrseloudis D, Lindsay AC, Dimopolous K, Alonso-Gonzalez R, Viceconte N, De Silva R, Di Mario C. Optical coherence tomography for guidance of distal cell recrossing in bifurcation stenting: choosing the right cell matters. EuroIntervention. 2012;8:205–13.CrossRefPubMedGoogle Scholar
- 37.Nakamura T, Okamura T, Fujimura T, Yamada J, Nao T, Tateishi H, Maeda T, Oda T, Shiraishi K, Nakashima T, Nishimura S, Miura T, Matsuzaki M, Yano M. Serial changes in the three-dimensional aspect of the side-branch ostium jailed by a drug-eluting stent assessed by optical coherence tomography. Int J Cardiovasc Imaging. 2017;33:797–806.CrossRefPubMedGoogle Scholar
- 38.Kurokawa M, Uemura S, Watanabe M, Dote Y, Sugawara Y, Goryo Y, Ueda T, Okayama S, Kayashima M, Saito Y. Changes in the reference lumen size of target lesions before and after coronary stent implantation: evaluation with frequency domain optical coherence tomography. IJC Heart Vasc. 2015;8:122–7.CrossRefGoogle Scholar
- 39.Chamie D, Bezerra HG, Attizzani GF, Yamamoto H, Kanaya T, Stefano GT, Fujino Y, Mehanna E, Wang W, Abdul-Aziz A, Dias M, Simon DI, Costa MA. Incidence, predictors, morphological characteristics, and clinical outcomes of stent edge dissections detected by optical coherence tomography. JACC Cardiovasc Interv. 2013;6:800–13.CrossRefPubMedGoogle Scholar
- 40.Ino Y, Kubo T, Matsuo Y, Yamaguchi T, Shiono Y, Shimamura K, Katayama Y, Nakamura T, Aoki H, Taruya A, Nishiguchi T, Satogami K, Yamano T, Kameyama T, Orii M, Ota S, Kuroi A, Kitabata H, Tanaka A, Hozumi T, Akasaka T. Optical coherence tomography predictors for edge restenosis after everolimus-eluting stent implantation. Circ Cardiovasc Interv. 2016;9:e004231.CrossRefPubMedGoogle Scholar
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.